Skip to content

Serotonin: all studies

Page 400 of 400: studies 3,991 to 3,999 of 3,999, newest first. Back to the serotonin overview

Research

Shared Neurobiological and Computational Mechanisms of Psychedelic, Contemplative, and Fasting-Induced Mystical Experience

Alex Jinich-Diamant preprint

Psychedelics, contemplative practice, and fasting are physiologically unrelated interventions that nevertheless converge, across cultures and centuries, on a common experiential endpoint: the mystical state. Here I propose that this convergence reflects shared disruption of a single computational architecture, the precision-weighted predictive hierarchy, through three mechanistically distinct...

MDMA-Based Psychotherapy in Treatment-Resistant Post-traumatic Stress Disorder (PTSD): A Brief Overview of Current Evidence

Preprints.org Kainat Riaz, Sejal Suneel, Mohammad Hamza Bin Abdul Malik et al. 1 citation preprint

Post-traumatic stress disorder (PTSD) is a debilitating mental health disorder that causes significant dysfunction in individuals. Currently, there are many approved Pharmacotherapy and Psychotherapy treatment options for PTSD, but unfortunately, half of the patients do not respond to traditional therapies. In this article, we reviewed clinical trials and research on...

Lysergic acid diethylamide stimulates cardiac human H 2 histamine receptors

Research Square Ulrich Gergs, Hannes Jacob, Pauline Braekow et al. 1 citation preprint

Abstract Introduction: Lysergic acid diethylamide (LSD) is an artificial hallucinogenic drug. Thus, we hypothesized that LSD might act 5-HT4 serotonin receptors and/or H2 histamine receptors. Methods: We studied isolated electrically stimulated left atrial preparations, spontaneously beating right atrial preparations, and spontaneously beating Langendorff-perfused hearts from transgenic mice...

Ketamine role in the treatment of Maternal depression: effects on offspring behaviour

Research Square Taqwa B. Thanoon, Zeina A. Althanoon preprint

Abstract Maternal depression during pregnancy adversely affects offspring neurodevelopment and behaviour. Typical antidepressants like selective serotonin reuptake inhibitors have limitations due to risks of crossing the placenta. Ketamine has emerged as a promising alternative treatment. This research examined ketamine's effects on offspring of maternally stressed mice. Dams were divided into...

Born Twice DMT and the Echo of Our First Conscious Experience

Tony R. Montgomery

Understanding how a simple endogenous tryptamine could occasion profound alterations in perception and self-modeling remains a key challenge for neuroscience. We advance the Birth Echo Hypothesis (BEH) : during a narrowly defined perinatal window (≈ −2 to +24 h around delivery), a convergence of hypoxic–hypercapnic stress, maximal sensory novelty, and a poly-neuromodulatory milieu...

Psychedelic Therapy: A Primer for Primary Care Clinicians—5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT)

Burton J. Tabaac, Kenneth Shinozuka, Anne Weisman et al. preprint

Background: 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), also officially known as Mebufotenin, is a naturally occurring serotonergic psychedelic alkaloid found in the venom of the Sonoran Desert toad (Incilius alvarius) and various plant species. Areas of Uncertainty: Trace levels of 5-MeO-DMT may be produced endogenously in humans, but its physiological role remains unclear. Safety profiles...

Psychedelic Therapy: A Primer for Primary Care Clinicians – Part III. N,N-dimethyltryptamine (DMT) and Ayahuasca

Kenneth Shinozuka, Burton J. Tabaac, Alejandro Arenas et al. preprint

Background: N,N-dimethyltryptamine (DMT) is a naturally-occurring serotonergic psychedelic found in natural plants around the globe. As the main psychoactive component in ayahuasca, which also contains monoamine oxidase (MAO) inhibitors, DMT has been consumed as plant-based brew by indigenous peoples for centuries. Further research is required to delineate the therapeutic utility of DMT.Areas...

Membrane Permeation of Psychedelic Compounds

ChemRxiv Vito Federico Palmisano, Claudio Agnorelli, Andrea Fagiolini et al. preprint

Renewed scientific interest in psychedelic compounds represents one of the most promising avenues for addressing the current burden of mental health disorders. Classic psychedelics are a group of compounds that exhibit structural similarities to the naturally occurring neurotransmitter serotonin (5-HT). Acting on the 5-HT type 2A receptors (5-HT2AR), psychedelics induce enduring...

DOI: 10.26434/chemrxiv-2023-wlxmw (opens in new tab) Psychedelics Drug design Membrane permeation Mental health +1

Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging

bioRxiv (Cold Spring Harbor Laboratory) Hanna M. Tolle, Andrea I. Luppi, Timothy Lawn et al. 1 citation preprint

Conventional antidepressants show moderate efficacy in treating major depressive disorder. Psychedelic-assisted therapy holds promise, yet individual responses vary, underscoring the need for predictive tools to guide treatment selection. Here, we present graphTRIP (graph-based Treatment Response Interpretability and Prediction) – a geometric deep learning architecture that enables three...

DOI: 10.1101/2025.07.02.662710 (opens in new tab) Psychedelic therapy Depression treatment Antidepressant therapy Mdd treatment +19